New technologies have the potential to revolutionize diabetes care. But what are the advantages and disadvantages of insulin pumps, vs. daily injections? How widely will they be adopted, by patients with type 2 diabetes as well as type 1? What factors will make a difference for adoption – convenience, accuracy, costs? In November, we asked you to help us examine the future of insulin delivery and find the answers to these questions. Now we’re sharing all the results with you, so that you can see for yourself how your fellow members of the diabetes community plan on using CGMs, now and in the future.
Read More »Eversense CGM System Part 3
In this week's Homerun Slides, understanding the sensor procedure for the Eversense CGM.
Read More »Eversense CGM System Part 2
In this week's Homerun Slides, explaining how the Eversense CGM System works.
Read More »Eversense CGM System Part 1
In this week's Homerun Slides, we begin a review of the new Eversense CGM system.
Read More »Omnipod Insulin Delivery System Receives FDA Clearance
The Omnipod Dash™ device approved for commercialization and release in the U.S. by mid-2018.
Read More »Is There a Future for BGM?
Guest Post by David Kliff, Editor, Diabetic Investor
With each passing day, it’s becoming more apparent that CGM will replace BGM as the standard for glucose measurement. CGM systems are becoming more patient-friendly, i.e. no calibrations, simple insertion, and cheaper too. The data provided by CGM is transformative, leading to improved outcomes. It is no longer a question of if this will happen but when this will happen.
ADA: CGM Comparisons — Advances, Pitfalls, and Clinical Relevance
Overview from a presentation at the 2018 American Diabetes Associations 78th Scientific Sessions.
Read More »ADA: Closed-Loop Insulin Delivery Improves Glycemic Management in Patients Who Are Hospitalized
The “artificial pancreas” provides glucose control for non-critically ill patients
Read More »New Closed-Loop Delivery System Improves Glycemic Control for People with T1D
Multi-center study compares closed-loop device to standard open-loop system in a home setting.
Read More »New Omnipod® Closed-Loop Insulin Delivery System Improves Glycemic Control
Hybrid closed-loop (HCL) system combines technology of CGM and insulin pumps, and a personalized, model-predictive control algorithm to deliver insulin day and night.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.